Minireview: Mechanisms by Which the Metabolic Syndrome and Diabetes Impair Memory
|
|
- Silas Barnett
- 5 years ago
- Views:
Transcription
1 Journal of Gerontology: BIOLOGICAL SCIENCES 2000, Vol. 55A, No. 5, B228 B232 Copyright 2000 by The Gerontological Society of America Minireview: Mechanisms by Which the Metabolic Syndrome and Diabetes Impair Memory Meena Kumari, Eric Brunner, and Rebecca Fuhrer B International Centre for Health and Society, Department of Epidemiology and Public Health, Royal Free and University College Medical School, London. Type 2 diabetes is associated with an increased risk of cognitive dysfunction. These effects seem particularly true for memory functions. This article examines how diabetes and the biological changes that occur with diabetes such as hyperglycemia, changes in insulin concentration, hypertension, and changes in lipid levels might lead to these alterations in cognitive functioning, with an emphasis on the mechanisms leading to changes in memory. OTH type 1 (insulin-dependent diabetes mellitus, or IDDM) and type 2 (non-insulin-dependent diabetes mellitus, or NIDDM) diabetes have detrimental effects on cognitive functioning (measures of verbal and numerical reasoning, attention, concentration, verbal and visual memory, and verbal fluency) and may increase the risk of dementia. In type 1 diabetes, chronic hyperglycemia and the recurrence of hypoglycemia appear to be associated with loss of cognitive ability (1 3). A recent review of cognition in type 2 diabetes concluded that despite the poor design and lack of statistical power in many studies, type 2 diabetes appears to be associated with an increased risk of cognitive dysfunction in a wide array of cognitive tests (4). These findings are borne out in larger epidemiological studies (5,6). In particular, in those studies that examined it, loss of verbal memory was most consistently associated with diabetes. This article examines how diabetes and its risk factors might lead to these changes in cognitive functioning, with a particular focus on memory. MEMORY A number of biological structures are involved in learning and memory; the hippocampus and associated areas are thought to be important in this regard (7), although no single brain structure is critical in and of itself (8). Similarly, a number of neurotransmitter systems have been implicated, including gamma-aminobutyric acid ergic systems and the cholinergic system. Particular emphasis has been placed on the loss of cholinergic function associated with memory loss in dementia. How might diabetes and its risk factors modulate brain cholinergic mechanisms (9)? The prevalence of type 2 diabetes increases with increasing age, which itself may be associated with decreased cognitive functioning and may independently account for some cognitive decline. Memory for remote past events appears to be intact with aging. In contrast, encoding and later retrieval of new information is compromised with increasing age. Thus, the negative effects of aging are reflected in a poorer performance in recall and recognition of lists of words or word pairs, memory for short paragraphs, and other verbal stimuli. Examinations of memory in elderly participants with type 2 diabetes have demonstrated a poorer performance in recent memory but not immediate recall (4). Recently, studies concerning the early stages of the disease and in the relatively young have attempted to distinguish the effects of diabetes on cognitive function from those caused by aging. An impaired performance on a battery of cognitive tests measuring immediate and delayed memory, attention, and verbal fluency was observed in nondiabetics with high 2-hour glucose and insulin following an oral glucose challenge (impaired glucose tolerance), which was similar in magnitude to the decrease seen in subjects with diabetes (10). Individuals younger than 55 years old with type 2 diabetes displayed a poorer performance on memory and attention tests than age- and education-matched controls (11). Thus, cognitive impairment may occur in the early subclinical stages of the progression to diabetes and in the relatively young. It would seem that diabetes and impaired glucose tolerance may lead to a decline in memory independently of aging, or alternatively that diabetes or the progression to diabetes represents a state of accelerated aging. DIABETES, THE METABOLIC SYNDROME, AND ITS COMPONENTS Diabetes is a complex metabolic disorder of heterogeneous aetiology. Type 1 diabetes occurs in the young and is characterized by a diminished secretion of insulin. The disease is thought to be autoimmune in nature. Type 2 diabetes is considerably more common and is characterized by insulin resistance. Age and obesity are major factors that contribute to the development of insulin resistance, and it has been estimated that 35% of the variability in insulin action can be explained by these two factors alone (12). The development of diabetes occurs in a number of overlapping rather arbitrary stages; initially or preceding the onset of overt diabetes, there is a period of insulin resistance that is characterized by a compensatory hyperinsulinemia to maintain normal glucose concentrations and the progression from normal to impaired glucose. Insulin resistance is associated with a constellation of factors termed the metabolic syndrome (also called syn- B228
2 METABOLIC SYNDROME AND COGNITION B229 drome X or insulin resistance syndrome), which in addition to hyperglycemia, and hyperinsulinemia is characterized by hypertension, dyslipidemia and increased central adiposity. This period may be followed by a decompensation of the system, with a relative decrease in insulin secretion that leads to the onset of overt diabetes. Symptoms associated with advanced diabetes (e.g., peripheral neuropathy) occur in the final stage. Evidence that the early stages described may be associated with changes in cognitive functioning suggest that the metabolic syndrome and its components (see above) may lead to changes in cognition. Although in vivo it is likely that the mechanisms discussed below act in concert with each other, for ease of discussion, the contributions of metabolic disturbances and hypertension are discussed separately here. The metabolic disturbances that occur in the metabolic syndrome are (a) hyperglycemia, (b) hyperinsulinemia, and (c) dyslipidemia. Additionally, hypertension is a component of the metabolic syndrome. Each will be discussed in turn. Hyperglycemia Both increases and decreases in glucose concentrations can potentially alter cognitive function. The detrimental effects of hypoglycemia on cognitive function are well documented. Both acute and chronic hypoglycemia in type 1 diabetes are associated with declines in measures that test intellectual functions and reaction time (1,13,14). In contrast, acute hyperglycemia might be expected to improve memory, as glucose, in addition to its metabolic function, acts as a substrate for acetylcholine and other neurotransmitters involved in memory and other cognitive processes (15,16). However, a number of lines of evidence suggest that chronically raised glucose concentrations lead to decreased cognitive functioning; poor glycemic control is associated with poor learning and memory, and the pharmacological improvement of glycemic control improves cognitive function test performance in alder adults, although it is unclear whether this is due to glucose control or to the pharmacological intervention (17). Animal studies suggest mechanisms by which raised glucose might induce these changes. Chronic, but not acute, hyperglycemia induced by streptozotocin leads to a decrease in acetylcholine synthesis and release in the brain of rats (18). Chronic hyperglycemia in rats also produces a significant loss of cortical neurons and, paradoxically, relative neuroglycopenia induced by decreased glucose transfer across the blood brain barrier. Loss of cortical neurons would result in cognitive impairment, as memory is thought to be stored in the cortex (8) and neuroglycopenia would result in decreased glucose availability as a substrate for acetylcholine. As noted previously, decreased cholinergic transmission would result in impaired memory. Hyperinsulinemia Insulin concentrations rise initially in the natural history of type 2 diabetes to compensate for defective insulin action, whereas in type 1 diabetes insulin secretion is diminished, leading to treatment with exogenous insulin administration. In some cases, insulin is also administered in the later stages of type 2 diabetes. Both animal and human studies provide evidence of a role for insulin in the impairment of a wide range of cognitive functions. High peak insulin response to glucose load has been found to be negatively correlated with learning ability in rats (19). In a study of over 5,500 subjects, direct effects of insulin on cognitive function were proposed. Serum insulin concentrations 2 hours following glucose challenge were associated with a poorer performance on the mini mental state examination (MMSE) (20) in nondiabetic women without dementia independently of cardiovascular risk factors and glucose levels (21). In elderly subjects with persistent impaired glucose tolerance, fasting insulin was associated with a poorer performance on the MMSE and in a test of long-term memory (10). Insulin treatment has also been associated with poorer performances in tests of verbal and visual memory (6). However, these data should be treated with caution, as insulin treatment occurs in severe diabetes that is resistant to other forms of treatment and thus may simply be a proxy for severity of diabetes. The effects of insulin in this regard require further investigation. A number of mechanisms can be postulated by which insulin might alter cognitive functioning. Serum insulin concentration is significantly associated with cerebrospinal fluid insulin, as insulin is transported across the blood brain barrier (22). Insulin receptors are present in the hypothalamus and hippocampus and mediate a decrease in cholinergic transmission (23,24). Hyperinsulinemia is also a risk factor for atherosclerosis, which is associated with cerebrovascular disease. However, although a direct effect of insulin on cognitive function is plausible, the role of a chronically increased insulin secretion in the context of diabetes is unclear, because hyperinsulinemia is not always apparent in type 2 diabetes. This is especially true in the later stages of the disease, when glucose toxicity may actually mediate diminished insulin secretion. The possible role of insulin in cognitive decline associated with diabetes therefore remains unclear and requires further investigation. Dyslipidemia Dyslipidemia is associated with the insulin resistance syndrome. A limited number of studies have suggested a role for raised triglyceride levels in cognitive impairment. Triglycerides are inversely associated with verbal fluency both cross-sectionally and prospectively (25) in diabetic patients. Hypertriglyceridemia in elderly patients with type 2 diabetes is associated with a decline in reaction times and backward digit span independently of any changes in glucose concentrations (25). High serum triglyceride levels are also associated with slower reaction times in a series of tests and with decreased verbal fluency in a small group of elderly subjects with normal glucose tolerance (26). Cognitive performance is also improved in patients treated with a triglyceride-lowering compound, gemfibrozil. Raised triglyceride concentrations are associated with atherosclerosis, and so the mechanism to alter cognition may be similar to that discussed for hypertension. Elevated triglyceride levels may also affect cognitive performance by increasing blood viscosity and impairing its rheological properties (27), which in turn might alter cerebral perfusion and accelerate atherosclerosis. In support of this hypothesis, a recent report has de-
3 B230 KUMARI ET AL. scribed a small negative association between delayed word recall and plasma fibrinogen in a cohort of 14,000 middleaged adults (28). Furthermore, there is tentative evidence from the findings that antithrombotic treatment (with aspirin or warfarin) is associated with better verbal fluency and mental flexibility (29). Hypertension and Cognitive Function Raised blood pressure is a risk factor commonly associated with insulin resistance syndrome and type 2 diabetes and has been the focus of much research on changes in cognitive function. There is a reduction in learning in spontaneously hypertensive rats, the most widely used animal model of essential hypertension, which is additive with that seen with age (30). This suggests that hypertension alters aspects of cognition. However, until recently the role of hypertension in cognitive impairment was equivocal in humans; as some studies found an association (31) whereas others did not (32). More recent studies examining the effects of raised blood pressure on changes in cognition over time have shown that hypertension does indeed lead to cognitive impairment. A recent report has demonstrated that type 2 diabetes and high blood pressure are independently associated with poorer performances on tests measuring immediate and delayed memory for prose and that higher diastolic blood pressure is associated with poorer performances on a measure of verbal fluency (6). In another study of nondiabetics, hyperinsulinemia in hypertension was associated with poor performances in cognitive tests reflecting calculation and verbal fluency (33). High diastolic blood pressure in men aged 50 years was also found to be associated with poorer performances on the MMSE 20 years later (34). How might hypertension cause changes in cognitive function? Again the cholinergic system can be implicated as, in the spontaneously hypertensive rat, decreased nicotinic receptor sensitivity to acetylcholine has been observed (35,36). A further mechanism that can be postulated is that hypertension is known to be associated with cerebrovascular disease, lacunar brain infarct, and brain white matter lesions. These alterations can be incurred directly or indirectly, for example, through accelerated atherosclerosis (37). Impaired cognitive performance in hypertension is associated with white matter lesions when an assessment is made by magnetic resonance imaging (38). DEMENTIA AND INSULIN RESISTANCE AND DIABETES Most cognitive abilities decline with advancing age, though the progression of mild cognitive impairment to dementia is not the most common evolution. The evidence is inconclusive as to whether cognitive impairment and dementia exist on a continuum or represent distinct processes (39). It is unclear whether the factors or processes that affect cognitive decline are the same as those that predict dementia. Dementia can be broadly split into two types; Alzheimer s type and vascular dementia. Alzheimer s disease (AD) is a degenerative brain disorder characterized by neuronal and synaptic degeneration and an increased number of senile plaques and neurofibrillary tangles compared with nondemented individuals of the same age. AD involves substantial loss of elements of a number of transmitter systems, the best described of which is the cholinergic system (40). AD is characterized by decreased brain glucose turnover, which results in decreased cholinergic transmission and memory impairment. The causes and pathogenesis of its most common form are multifactorial and are largely unknown. Vascular dementia is less common and is caused by cerebrovascular and ischemic brain damage, that is, a combination of multiple cerebral infarcts, lacunas, and ischemic white matter lesions, a demyelination of the periventricular white matter. One of the best known risk factors for developing Alzheimer s disease is carrying the 4 allele of the apolipoprotein E (Apo 4) gene, but it is not necessary to carry the Apo 4 allele to develop Alzheimer s disease (41). Recent studies have reported an association between features of the insulin resistance syndrome (hyperglycemia and hyperinsulinemia) and newly detected Alzheimer s disease (5,42). Incidence of AD reported in this study was as high in the insulin resistance group as in the carriers of the Apo 4 allele (42). In addition to the mechanisms by which hyperglycemia might lead to cognitive impairment discussed above, it can be hypothesized that hyperglycemia might mediate accelerated progression of AD by means of advanced glycation endproducts (AGEs). These are products of glycation of proteins, and they accumulate in tissues as a function of time and blood glucose concentrations. They are found in amyloid plaques of AD (43) and are thought to accelerate the plaque deposition that occurs in AD. Thus, hyperglycemia and hence an increased production of AGEs may contribute to the formation of amyloid plaques in AD. This hypothesis requires further investigation. Vascular dementia is caused by cerebrovascular and ischemic brain damage. Several lines of evidence suggest that multiple infarcts and ischemic white matter lesions associated with hypertension are vascular causes of dementia. Performances on the MMSE were worse in a hypertensive group with white matter lesions than in the normotensive group and hypertensive group without such lesions. White matter lesions also occur in Alzheimer s disease, indicating a role for hypertension in the etiology of both types of dementia. Hypertension and white matter lesions are strongly implicated in the etiology of a particular dementia syndrome, Binswanger s syndrome (44). A recent longitudinal study reported that raised blood pressure predicted the incidence of both vascular dementia and Alzheimer s disease after 15 years (45,46), suggesting that hypertension is indeed a risk factor for dementia. CONCLUSIONS There is now substantial evidence to support the conclusion that type 2 diabetes is associated with memory impairment and dementia. These alterations in cognitive function may represent accelerated aging in diabetes, although evidence in this regard is poor. There is literature suggesting that both the metabolic control and the hypertension that occurs as a consequence of diabetes are involved in the etiology of the cognitive impairment that may occur. The literature on the mechanisms with regard to cognitive impairment is unclear. Evidence suggests a role for glycemic control in both memory decline and dementia. The role of insulin, hypertension,
4 METABOLIC SYNDROME AND COGNITION B231 and dyslipidemia in loss of memory functions is less convincing, although these factors are associated with decline in other functions such as verbal fluency. Their role in dementia is also apparent. It is unclear if these factors are using the same or different mechanisms to cause these changes in cognition. It is possible that different pathways may converge in the case of dementia. The literature describing cholinergic transmission and factors associated with diabetes has been highlighted in this article. A number of transmitter pathways that are associated with memory and cognitive functioning have not been discussed. More research is needed to further characterize these mechanisms. The association between factors associated with diabetes and cognitive function as well as dementia provides the individual with means to control the onset of these consequences of aging and pathology by modification of lifestyle and behavior. Acknowledgments M. Kumari, E. Brunner, and R. Fuhrer are members of the Whitehall II study team. The Whitehall II study has been supported by grants from the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute (R01 HL36310), US, NIH: National Institute on Aging (R01 AG13196), US, NIH; Agency for Health Care Policy Research (R01 HS06516); and the John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. R. Fuhrer is a Research Scientist with INSERM (Institut National de la Santé et de la Recherche Médicale, Paris, France) presently on leave to University College, London. Address correspondence to Dr. Meena Kumari, International Centre for Health and Society, Department of Epidemiology and Public Health, Royal Free and University College Medical School, London, WC1 6BT, UK. m.kumari@public-health.ucl.ac.uk References 1. Langan SJ, Deary IJ, Hepburn DA, Frier BM. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia. 1991;34: Amiel SA, Gale E. Physiological responses to hypoglycemia. Diabetes Care. 1993;16: Lincoln NB, Faleiro RM, Kelly C, Kirk BA, Jeffcoate WJ. Effect of long-term glycemic control on cognitive function. Diabetes Care. 1996;19: Strachan MWJ, Deary IJ, Ewing FME, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? Diabetes Care. 1997;20: Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MMB. Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia. 1996;39: Elias PK, Elias MF, D Agostino RB, et al. NIDDM and blood pressure as risk factors for poor cognitive functioning. The Framingham Study. Diabetes Care. 1997;20: Hasselmo ME, Wyble BP, Wallenstein GV. Encoding and retrieval of episodic memories: role of cholinergic and GABAergic modulation in the hippocampus. Hippocampus. 1996;6: Redish AD, Touretzky DS. Cognitive maps beyond the hippocampus. Hippocampus. 1997;7: Everitt BJ, Robbins TW. Central cholinergic systems and cognition. Ann Rev Psychol. 1997;48: Vanhanen M, Koivisto K, Karjalainen L, et al. Risk for non-insulindependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function. Neuroreport. 1997;8: Dey J, Misra A, Desai NG, Mahapatra AK, Padma MV. Cognitive function in younger type II diabetes. Diabetes Care. 1997;20: DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. In: Alberti KGMM, Zimmet P, DeFronzo RA, Keen H, eds. International Textbook of Diabetes Mellitus. 2nd ed. New York: Wiley; 1997: Deary IJ, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM. Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes. 1993;42: Draelos MT, Jacobson AM, Weinger K, et al. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med. 1995;98: Sherman KA, Gibson GE, Perrino P, Garrett K. Acetylcholine formation from glucose following acute choline supplementation. Neurochem Res. 1991;16: Ragozzini ME, Unick KE, Gold PE. Hippocampal acetylcholine release during memory testing in rats: Augmentation by glucose. Proc Natl Acad Sci USA. 1996;93: Gradman TJ, Laws A, Thomson LW, Reaven GM. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc. 1993;41: Welsh B, Wecker L. Effects of Streptozotocin-induced diabetes on acetylcholine metabolism in rat brain. Neurochem Res. 1991;16: Long JM, Davis BJ, Garofalo P, Spangler EL, Ingram DK. Complex maze performance in young and aged rats: response to glucose treatment and relationship to blood insulin and glucose. Physiol Behav. 1992;51: Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12: Stolk RP, Breteler MMB, Ott A, et al. Insulin and cognitive function in an elderly population. Diabetes Care. 1997;20: Baura GD, Foster DM, Porte D, et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest. 1993;92: Shibata S, Liou SY, Ueki S, Oomura Y. Inhibitory action of insulin on suprachiasmatic nucleus neurons in rat hypothalamic slice preparations. Physiol Behav. 1986;36: Palovcik RA, Phillips MI, Kappy MS, Raizada MK. Insulin inhibits pyramidal neurons in hippocampal slices. Brain Res. 1984;309: Perlmuter LC, Goldfinger SH, Shore AR, et al. Cognitive function in non-insulin-dependent diabetes. In: Holmes CS, ed. Neuropsychological and Behavioural Aspects of Diabetes. New York: Springer-Verlag; 1990: Helkala E, Niskanen L, Viinamaki H, Partanen J, Uusitupa M. Shortterm and long-term memory in elderly patients with NIDDM. Diabetes Care. 1995;18: Koenig W, Sund M, Ernst E, Mraz W, Hombach V, Keil U. Association between rheology and components of lipoproteins in human blood. Circulation. 1992;85: Cerhan JR, Folsom AR, Mortimer JA, et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology. 1998;44: Richards M, Meade TW, Peart SS, Brennan PJ, Mann AH. Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings. J Neurol Neurosurg Psychiatry. 1997;62: Meneses A, Castillo C, Ibarra M, Hong E. Effects of aging and hypertension on learning, memory and activity in rats. Physiol Behav. 1996; 60: Elias MF, Wolf PA, D Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham study. Am J Epidemiol. 1993;6: Scherr PA, Hebert LE, Smith LA, Evans DA. Relation of blood pressure to cognitive function in elderly. Am J Epidemiol. 1991;134: Kuusisto J, Koivisto K, Mykkanen L, et al. Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension. 1993; 22: Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: a 20-year follow up of 999 men. Hypertension. 1998;31: Gattu M, Pauly JR, Boss KL, Summers JB, Buccafusco JJ. Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I. Brain Res. 1997;771: Gattu M, Terry AV, Pauly JR, Buccafusco JJ. Cognitive impairment in
5 B232 KUMARI ET AL. spontaneously hypertensive rats: role of central nicotinic receptors. Part II. Brain Res. 1997;771: Bots ML, van Swieten JC, Breteler MMB, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet. 1993;341: Breteler MMB, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a populationbased study: the Rotterdam Study. Neurology. 1994;44: Huppert FA, Whittington JE, eds. Dementia and normal ageing. Cambridge: Cambridge University Press; Kasa P, Rakonczay Z, Gulya K. The cholinergic system in Alzheimer s disease. Prog Neurobiol. 1997;52: Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer s disease. Annu Rev Med. 1996;47: Kuusisto J, Koivisto K, Mykkanen L, et al. Association between features of the insulin resistance syndrome and Alzheimer s disease independently of apolipoprotein E4 phenotype: cross sectional population based study. Br Med J. 1997;315: Li YM, Dickson DW. Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer s disease. Neurosci Lett. 1997;226: Olsen CG, Clasen ME. Senile dementia of the Binswanger s type. Am Fam Physician. 1998;58: Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347: Ross GW, Launer LJ, Petrovitch H, et al. The association between midlife blood pressure and dementia: The Honolulu-Asia Aging Study. Neurology. 1998;50:A229. Received April 2, 1999 Accepted September 21, 1999 Decision Editor: Jay Roberts, PhD
The Primary Care Guide To Understanding The Role Of Diabetes As A Risk Factor For Cognitive Loss Or Dementia In Adults
The Primary Care Guide To Understanding The Role Of Diabetes As A Risk Factor For Cognitive Loss Or Dementia In Adults. Introduction Glucose intolerance is common in older individuals and this metabolic
More informationDiabetes Mellitus and Dementia. Andrea Shelton & Adena Zadourian
Diabetes Mellitus and Dementia Andrea Shelton & Adena Zadourian Abstract Diabetes mellitus increases the risk for developing dementia...but there is inconsistency with the subtypes of dementia Diabetes
More informationChapter 1. Introduction
The older people get, the bigger the chance of losing cognitive abilities and ultimately to develop dementia. Increasing age is the largest known risk factor of dementia, with a prevalence of 1% in people
More informationKey Words: Hypertension, Blood pressure, Cognitive impairment, Age 대한신경과학회지 22 권 1 호
Seul-Ki Jeong, M.D., Hae-Sung Nam, M.D., Min-Ho Shin, M.D., Sun-Seok Kweon, M.D., Myong-Ho Son, M.D., Eui-Ju Son, M.D., Jae-Min Kim, M.D., Ki-Hyun Cho, M.D. Background: It has been reported that the association
More informationNeurocognitive impairment in patients of diabetes mellitus
ORIGINAL ARTICLE Neurocognitive impairment in patients of diabetes mellitus R K Solanki, Vaibhav Dubey, Paramjeet Singh, Deepti Munshi, Mukesh Kr. Swami Abstract : This study was conducted to find out
More informationAssociation of diabetes mellitus and dementia: The Rotterdam Study
Diabetologia (1996) 39: 1392 1397 Springer-Verlag 1996 Association of diabetes mellitus and dementia: The Rotterdam Study A. Ott 1, R. P. Stolk 1, A. Hofman 1, F. van Harskamp 2, D.E. Grobbee 1, M. M.
More informationIN ADDITION TO THE WELL-DOCUmented
ORIGINAL CONTRIBUTION Enhanced Risk for Alzheimer Disease in Persons With Type 2 Diabetes and APOE 4 The Cardiovascular Health Study Cognition Study Fumiko Irie, MD, PhD, MPH; Annette L. Fitzpatrick, PhD;
More information28/04/51. Introduction. Insulin signaling effects on memory and mood. Is accelerated brain aging a consequence of diabetes? chronic hyperglycemia
Introduction Insulin signaling effects on memory and mood (Review) Diabetes mellitus is a chronic disease resulting from defects in insulin secretion, insulin action, or both Long-term diabetes Lawrence
More informationThe Primary Care Guide To Understanding The Role Of The Metabolic Syndrome In Cognitive Decline Of Older Persons
The Primary Care Guide To Understanding The Role Of The Metabolic Syndrome In Cognitive Decline Of Older Persons 1. Defining the Metabolic Syndrome A Primary care practice often includes numerous patients
More informationORIGINAL CONTRIBUTION. Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
ORIGINAL CONTRIBUTION Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease Miia Kivipelto, MD, PhD; Tiia Ngandu, BM; Laura Fratiglioni, MD, PhD; Matti Viitanen, MD,
More informationChapter 4. Cognitive decline precedes late-life longitudinal changes in vascular risk factors
Cognitive decline precedes late-life longitudinal changes in vascular risk factors P. van Vliet, R.G.J. Westendorp, D. van Heemst, A.J.M. de Craen, A.M. Oleksik J Neurol Neurosurg Psychiatry 2010;81:1028-1032
More informationKA Toulis, K. Dovas, M. Tsolaki. The endocrine facets of Alzheimer s disease and dementia-related disorders
KA Toulis, K. Dovas, M. Tsolaki The endocrine facets of Alzheimer s disease and dementia-related disorders Sex hormones Calcium metabolism GH/IGF-I Thyroid axis Metabolic hormones + dementia Sex hormones
More informationVascular dementia (VaD) is preceded by several years of
Cognitive Functioning in Preclinical Vascular Dementia A 6-Year Follow-Up Erika Jonsson Laukka, MSc; Sari Jones, MSc; Laura Fratiglioni, MD, PhD; Lars Bäckman, PhD Background and Purpose Recent studies
More informationExtensive literature has been published
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E A Biethnic Community Survey of Cognition in Participants With Type 2 Diabetes, Impaired Glucose Tolerance, and Normal Glucose
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/42751 holds various files of this Leiden University dissertation Author: Foster-Dingley, J.C. Title: Blood pressure in old age : exploring the relation
More informationPost Stroke Cognitive Decline
Post Stroke Cognitive Decline Deborah A. Levine, MD, MPH Departments of Medicine & Neurology University of Michigan deblevin@umich.edu Presenter Disclosure Information Deborah A. Levine, MD, MPH Post Stroke
More informationA Dynamic Model of Care for Late Onset Cognitive Impairment. Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong
A Dynamic Model of Care for Late Onset Cognitive Impairment Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong Outline The pathogenesis of Late life cognitive impairment A framework
More informationBrain Health and Risk Factors for Dementia
Welcome To Brain Health and Risk Factors for Dementia Presented by Kamal Masaki, MD Professor and Chair Department of Geriatric Medicine John A. Burns School of Medicine, UH Manoa April 4, 2018 10:00 11:00
More informationALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey
ALZHEIMER S DISEASE Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey Topics Covered Demography Clinical manifestations Pathophysiology Diagnosis Treatment Future trends Prevalence and Impact
More informationCharacteristics of neuropsychological functions in inpatients with poorly-controlled type 2 diabetes mellitus
ORIGINAL ARTICLE Characteristics of neuropsychological functions in inpatients with poorly-controlled type 2 diabetes mellitus Ai Takeuchi 1 *, Eisuke Matsushima 1, Motoichiro Kato 2, Mika Konishi 2, Hajime
More informationObesity, diabetes and cognitive deficit: The Framingham Heart Study
Neurobiology of Aging 26S (2005) S11 S16 Obesity, diabetes and cognitive deficit: The Framingham Heart Study Merrill F. Elias a,b,, Penelope K. Elias a,b, Lisa M. Sullivan a,c, Philip A. Wolf d, Ralph
More informationThe current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease
The current state of healthcare for Normal Aging, g, Mild Cognitive Impairment, & Alzheimer s Disease William Rodman Shankle, MS MD FACP Director, Alzheimer s Program, Hoag Neurosciences Institute Neurologist,
More informationDementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology
Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language
More informationMetabolic syndrome is a constellation of cardiovascular
and Cognitive Decline in Elderly Latinos: Findings from the Sacramento Area Latino Study of Aging Study Kristine Yaffe, MD, wzk Mary Haan, DrPH, MPH, z Terri Blackwell, MA, # Elena Cherkasova, BA, Rachel
More informationA Review on Relationship between Type II Diabetes and Cognitive Impairment
REVIEW ARTICLE A Review on Relationship between Type II Diabetes and Cognitive Impairment Downloaded from ijdo.ssu.ac.ir at 12:07 IRST on Wednesday January 23rd 2019 1. MSc Student of Medical Journalism,
More informationUNIVERSITY OF WESTERN ONTARIO
UNIVERSITY OF WESTERN ONTARIO Vladimir Hachinski, CM, MD, FRCPC, DSc Department of Clinical Neurological Sciences University of Western Ontario London, Ontario, Canada Vladimir.hachinski@lhsc.on.ca ALZHEIMER
More informationLong-term follow-up studies suggest that elevated blood
Decline in Blood Pressure Over Time and Risk of Dementia A Longitudinal Study From the Kungsholmen Project Chengxuan Qiu, MD, PhD; Eva von Strauss, PhD; Bengt Winblad, MD, PhD; Laura Fratiglioni, MD, PhD
More informationHOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE?
EAMA CORE CURRICULUM HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE? Sofia Duque Orthogeriatric Unit São Francisco Xavier Hospital Occidental Lisbon Hospital Center University Geriatric Unit, Faculty of
More informationThe impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors
Feinkohl et al. Alzheimer's Research & Therapy (2015) 7:46 DOI 10.1186/s13195-015-0130-5 REVIEW The impact of on cognitive decline: potential vascular, metabolic, and psychosocial risk factors Insa Feinkohl
More informationAssessing Cognition. Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin
Assessing Cognition Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin Agenda Topic: Cognitive Aging Assessing Cognition Diagnosing Cognitive Impairment Dementia Diagnoses Symptoms
More informationLow Diastolic Blood Pressure and High Blood Pressure Variability are Risk Factors for Cognitive Decline in Elderly Adults: A Case-Control Study
Low Diastolic Blood Pressure and High Blood Pressure Variability are Risk Factors for Cognitive Decline in Elderly Adults: A Case-Control Study Chia-Chi Chen 1, Jia-Fu Lee 2,3,, Yu-Lin Ko 4, Chun-Te Lee
More informationdeath if the deficit is prolonged. Children and adults exposed to hypoglycaemia can develop long-term impairment of cognitive function (Blattner,
Introduction Glucose is the primary source of fuel for the cells of the brain. Brain is dependent on a continuous supply of glucose diffusing from the blood into the interstitial tissue within the central
More informationSUPPLEMENTARY APPENDIX
Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 23 million people and more than 100,000 cases of dementia SUPPLEMENTARY APPENDIX Supplementary Methods Newcastle
More informationChapter 11 summary definitief ineke brands.indd :57:59
chapter 11 Summary chapter 11 Both type 1 and type 2 diabetes mellitus are associated with altered brain function, a complication referred to as diabetic encephalopathy. Previous studies have shown that
More informationEPIDEMIOLOGY AND RISK FACTORS OF DEMENTIA
v2 EPIDEMIOLOGY AND RISK FACTORS OF DEMENTIA See end of article for authors affiliations Correspondence to: W M van der Flier, Department of Neurology and Alzheimer Center, Vrije Universiteit Medical Center,
More informationThe Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging
The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging REBECCA F. GOTTESMAN, MD PHD ASSOCIATE PROFESSOR OF NEUROLOGY AND EPIDEMIOLOGY JOHNS HOPKINS UNIVERSITY OCTOBER 20, 2014 Outline
More informationBlood Pressure and Performance on the Mini-Mental State Examination in the Very Old
American Journal of Epidemiology Copyright 1997 by The Johns Hopkins University School of Hygiene and ublic Health All rights reserved Vol. 145,. 12 rinted In USA. Blood ressure and erformance on the Mini-Mental
More informationMetabolic Syndrome: What s in a name?
Commentary Metabolic Syndrome: What s in a name? Deborah P. Wubben, MD, MPH; Alexandra K. Adams, MD, PhD Abstract The term metabolic syndrome has recently become en vogue. But is the definition realistic,
More informationThe importance of cognitive ageing for understanding dementia
The importance of cognitive ageing for understanding dementia Archana Singh-Manoux, PhD 1,2,3 Mika Kivimäki, PhD 2 * Corresponding author & address: 1 Centre for Research in Epidemiology & Population Health,
More informationWHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient
DEMENTIA WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of
More informationErin Cullnan Research Assistant, University of Illinois at Chicago
Dr. Moises Gaviria Distinguished Professor of Psychiatry, University of Illinois at Chicago Director of Consultation Liaison Service, Advocate Christ Medical Center Director of the Older Adult Program,
More information1,2. Diabetes Care 26: , 2003
Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E Carbohydrate-Induced Memory Impairment in Adults With Type 2 Diabetes CAROL E. GREENWOOD, PHD 1,2 RANDALL J. KAPLAN, PHD 1,2 1,2 STACEY HEBBLETHWAITE,
More informationA Meta-analysis of Cognitive Functioning in Non- Demented Adults with Type 2 Diabetes Mellitus
University of Windsor Scholarship at UWindsor Electronic Theses and Dissertations 2012 A Meta-analysis of Cognitive Functioning in Non- Demented Adults with Type 2 Diabetes Mellitus Michelle Cécile Émélie
More informationORIGINAL INVESTIGATION. Plasma C Peptide Level and Cognitive Function Among Older Women Without Diabetes Mellitus
ORIGINAL INVESTIGATION Plasma C Peptide Level and Cognitive Function Among Older Women Without Diabetes Mellitus Olivia Okereke, MD, SM; Susan E. Hankinson, ScD; Frank B. Hu, MD, PhD; Francine Grodstein,
More informationNeurodegenerative disorders and diabetes: common underlying impairments. N.M. Lalic (Serbia)
Neurodegenerative disorders and diabetes: common underlying impairments N.M. Lalic (Serbia) Neurodegenerative disorders and diabetes: common underlying impairments Professor Nebojsa M. Lalic Faculty of
More informationCognitive Abilities Screening Instrument, Chinese Version 2.0 (CASI C-2.0): Administration and Clinical Application
Continuing Medical Education 180 Cognitive Abilities Screening Instrument, Chinese Version 2.0 (CASI C-2.0): Administration and Clinical Application Ker-Neng Lin 1,2, Pei-Ning Wang 1,3, Hsiu-Chih Liu 1,3,
More informationIs socioeconomic position related to the prevalence of metabolic syndrome? Influence of
Is socioeconomic position related to the prevalence of metabolic syndrome? Influence of social class across the life-course in a population-based study of older men Sheena E Ramsay, MPH 1, Peter H Whincup,
More informationMild Cognitive Impairment (MCI)
October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine
More informationEfficacy of Donepezil Treatment in Alzheimer Patients with and without Subcortical Vascular Lesions
Short Communication Pharmacology 2004;72:1 5 DOI: 10.1159/000078625 Received: January 27, 2004 Accepted after revision: February 23, 2004 Efficacy of Donepezil Treatment in Alzheimer Patients with and
More informationInsulin and Neurodegenerative Diseases: Shared and Specific Mechanisms. Cogs 163 Stella Ng Wendy Vega
Insulin and Neurodegenerative Diseases: Shared and Specific Mechanisms Cogs 163 Stella Ng Wendy Vega Overview A. Insulin and the Brain B. Alzheimer s Disease and Insulin C. Other neurodegenerative disease:
More informationORIGINAL INVESTIGATION. Body Mass Index, Other Cardiovascular Risk Factors, and Hospitalization for Dementia
ORIGINAL INVESTIGATION Body Mass Index, Other Cardiovascular Risk Factors, and Hospitalization for Dementia Annika Rosengren, MD, PhD; Ingmar Skoog, MD, PhD; Deborah Gustafson, PhD; Lars Wilhelmsen, MD,
More informationORIGINAL INVESTIGATION
Effects of Blood Pressure Lowering With Perindopril and Indapamide Therapy on Dementia and Cognitive Decline in Patients With Cerebrovascular Disease The PROGRESS Collaborative Group* ORIGINAL INVESTIGATION
More informationTHE INFLUENCE OF CARDIOVAScular
ORIGINAL CONTRIBUTION The Role of APOE 4 in Modulating Effects of Other s for Cognitive Decline in Elderly Persons Mary N. Haan, MPH, DrPH Lynn Shemanski, PhD, MHS William J. Jagust, MD Teri A. Manolio,
More informationNIH Public Access Author Manuscript Metab Brain Dis. Author manuscript; available in PMC 2011 October 24.
NIH Public Access Author Manuscript Published in final edited form as: Metab Brain Dis. 2006 September ; 21(2-3): 235 240. doi:10.1007/s11011-006-9017-2. Risk factors for incident Alzheimer s disease in
More informationThe prevalence and incidence of degenerative and vascular dementias increase exponentially
REVIEW ARTICLE Blood Pressure, Cognitive Functions, and Prevention of Dementias in Older Patients With Hypertension Willem H. Birkenhäger, MD, PhD; Françoise Forette, MD, PhD; Marie-Laure Seux, MD; Ji-Guang
More informationDiabetes and Risk of Dementia Luchsinger et al. Diabetes Mellitus and Risk of Alzheimer s Disease and Dementia with Stroke in a Multiethnic Cohort
American Journal of Epidemiology Copyright 2001 by the Johns Hopkins University Bloomberg School of Public Health All rights reserved Vol. 154, No. 7 Printed in U.S.A. Diabetes and Risk of Dementia Luchsinger
More informationHow does exercise benefit people at risk for dementia?
How does exercise benefit people at risk for dementia? Neva J. Kirk-Sanchez, PhD, PT University of Miami Miller School of Medicine Department of Physical Therapy Brain processes that show greatest rates
More informationThe effect of glycemic control on executive functions in elderly patients with type 2 diabetes mellitus.
Research Article http://www.alliedacademies.org/journal-mental-health-aging/ The effect of glycemic control on executive functions in elderly patients with type 2 diabetes mellitus. Hend F Mahmoud *, Marwa
More informationType 2 Diabetes Mellitus and CNS
Type 2 Diabetes Mellitus and CNS Grigorios Nasios, MD, Ph.D Neurologist, Associate Professor, TEI of Epirus, Department of Speech and Language Therapy, Ioannina, Greece nasios@ioa.teiep.gr 1 Whenever You
More informationDementia. Assessing Brain Damage. Mental Status Examination
Dementia Assessing Brain Damage Mental status examination Information about current behavior and thought including orientation to reality, memory, and ability to follow instructions Neuropsychological
More informationSeveral lines of investigation have suggested that inflammation
Systemic Markers of Inflammation and Cognitive Decline in Old Age Miranda T. Schram, PhD, w Sjoerd M. Euser, MSc, w Anton J. M. de Craen, PhD, Jacqueline C. Witteman, PhD, w Marijke Frölich, PhD, Albert
More informationThe maintenance of cognitive abilities is an important
Apolipoprotein E Genotypes: Relationship to Cognitive Functioning, Cognitive Decline, and Survival in Nonagenarians Lise Bathum, MD, PhD, w Lene Christiansen, MSC, PhD, w Bernard Jeune, MD, w James Vaupel,
More informationNeuropsychological Evaluation of
Neuropsychological Evaluation of Alzheimer s Disease Joanne M. Hamilton, Ph.D. Shiley-Marcos Alzheimer s Disease Research Center Department of Neurosciences University of California, San Diego Establish
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More informationChapter 7. Depression and cognitive impairment in old age: what comes first?
Chapter 7 Depression and cognitive impairment in old age: what comes first? Vinkers DJ,Gussekloo J,StekML,W estendorp RGJ,van der Mast RC. Depression and cognitive impairment in old age: what comes first?
More informationCOGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E
COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E Attention Problem Solving Language Cognitive Domains Decision Making Memory Reasoning The Cardiovascular Health Cognition Study shows higher S
More informationBiochimica et Biophysica Acta
Biochimica et Biophysica Acta 1792 (2009) 470 481 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbadis Review Type 2 diabetes mellitus,
More informationutilization is decreased in the brain during diabetes (McCall, 1992), providing a potential mechanism for increased vulnerability to acute
Introduction Homeostasis of blood and cellular glucose is an important factor of body functioning as a whole and the nervous system in particular. Glucose is the principal source for energy production
More informationSocioeconomic status risk factors for cardiovascular diseases by sex in Korean adults
, pp.44-49 http://dx.doi.org/10.14257/astl.2013 Socioeconomic status risk factors for cardiovascular diseases by sex in Korean adults Eun Sun So a, Myung Hee Lee 1 * a Assistant professor, College of Nursing,
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Cognitive impairment evaluated with Vascular Cognitive Impairment Harmonization Standards in a multicenter prospective stroke cohort in Korea Supplemental Methods Participants From
More informationUDS Progress Report. -Standardization and Training Meeting 11/18/05, Chicago. -Data Managers Meeting 1/20/06, Chicago
UDS Progress Report -Standardization and Training Meeting 11/18/05, Chicago -Data Managers Meeting 1/20/06, Chicago -Training material available: Gold standard UDS informant and participant interviews
More informationThe Impact of the Use of Statins on the Prevalence of Dementia and the Progression of Cognitive Impairment
Journal of Gerontology: MEDICAL SCIENCES 2002, Vol. 57A, No. 7, M414 M418 Copyright 2002 by The Gerontological Society of America The Impact of the Use of Statins on the Prevalence of Dementia and the
More informationType 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky
Type 2 Diabetes and Brain Disease in Older Adults Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky Disclosures to Participants Requirements for Successful Completion: For successful completion,
More informationANIMAL MODELS OF ALZHEIMER'S DISEASE: ARE THEY VALID AND USEFUL?
ACTA NEUROBIOL. EXP. 1990, 50: 219-223 Symposium "Recovery from brain damage: behavioral and neurochemical approaches'' 4-7 July, 1989, Warsaw, Poland ANIMAL MODELS OF ALZHEIMER'S DISEASE: ARE THEY VALID
More informationVascular and Degenerative Causes of Cognitive Impairment: How are they linked?
Vascular and Degenerative Causes of Cognitive Impairment: How are they linked? MCI Symposium, Public Education Forum Presented by: Rebecca Gottesman, MD PhD January 20, 2019 1 Disclosures I am an Associate
More informationObjective 4/22/2019. Interaction of Cardiovascular Disease and Alzheimer s Disease: Implications for Cardiopulmonary Rehabilitation.
Interaction of Cardiovascular Disease and Alzheimer s Disease: Implications for Cardiopulmonary Rehabilitation Dereck Salisbury, PhD Assistant Professor, Clinical Exercise Physiologist Director: Laboratory
More informationInteraction of Cardiovascular Disease and Alzheimer s Disease: Implications for Cardiopulmonary Rehabilitation
Interaction of Cardiovascular Disease and Alzheimer s Disease: Implications for Cardiopulmonary Rehabilitation Dereck Salisbury, PhD Assistant Professor, Clinical Exercise Physiologist Director: Laboratory
More informationClinical Study Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer s and Cognitively Normal Elderly
Hindawi Publishing Corporation Depression Research and Treatment Volume 2011, Article ID 396958, 6 pages doi:10.1155/2011/396958 Clinical Study Depressive Symptom Clusters and Neuropsychological Performance
More informationPrediction of severe hypoglycemia. Additional information for this article can be found in an online appendix at
Diabetes Care In Press, published online March 15, 2007 Prediction of severe hypoglycemia Received for publication 3 July 2006 and accepted in revised form 7 March 2007. Additional information for this
More informationCASE 49. What type of memory is available for conscious retrieval? Which part of the brain stores semantic (factual) memories?
CASE 49 A 43-year-old woman is brought to her primary care physician by her family because of concerns about her forgetfulness. The patient has a history of Down syndrome but no other medical problems.
More informationSilent Brain Infarcts and the Risk of Dementia and Cognitive Decline
The new england journal of medicine original article Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline Sarah E. Vermeer, M.D., Ph.D., Niels D. Prins, M.D., Tom den Heijer, M.D., Albert
More informationBaseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston
Article ID: ISSN 2046-1690 Baseline Characteristics of Patients Attending the www.thealzcenter.org Memory Clinic Serving the South Shore of Boston Corresponding Author: Dr. Anil K Nair, Chief of Neurology,
More informationRecent publications using the NACC Database. Lilah Besser
Recent publications using the NACC Database Lilah Besser Data requests and publications Using NACC data Number of requests by year Type 2009 2010 2011 2012 2013 2014 2015 Data files* 55 85 217 174 204
More informationPharmacologyonline 3: (2010)
PERSEVERATIONS IN ALZHEIMER DISEASE: ANALYSIS OF THE DISTURBANCE AND POSSIBLE CORRELATIONS M. D Antonio¹, L. Trojano², M. R. De Riso², D. Grossi ² and A. M. Fasanaro¹, ¹Alzheimer Unit, Neurology Department,
More informationINTERRELATED biological factors in addition to age can. Type 2 Diabetes Is Negatively Associated With Alzheimer s Disease Neuropathology
Journal of Gerontology: MEDICAL SCIENCES 2005, Vol. 60A, No. 4, 471 475 Copyright 2005 by The Gerontological Society of America Type 2 Diabetes Is Negatively Associated With Alzheimer s Disease Neuropathology
More informationNeuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia
86 Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia Pai-Yi Chiu 1,3, Chung-Hsiang Liu 2, and Chon-Haw Tsai 2 Abstract- Background: Neuropsychiatric profile
More informationAssessment of Cognitive Performance in Prehypertensives and Normotensives in the age group years
International Journal of Medical Science and Clinical Invention 4(12): 3341-3345, 2017 DOI:10.18535/ijmsci/v4i12.1 ICV 2016: 77.2 e-issn:2348-991x, p-issn: 2454-9576 2017,IJMSCI Research Article Assessment
More informationEvaluation of Preventive Care Program for Cognitive Function Decline among Community-dwelling Frail Elderly People A Pilot Study
Journal of Japan Academy of Community Health Nursing Vol. 9, No. 2, pp. 87 92, 2007 Evaluation of Preventive Care Program for Cognitive Function Decline among Community-dwelling Frail Elderly People A
More informationEuropean Prevention of Alzheimer s Dementia (EPAD)
European Prevention of Alzheimer s Dementia (EPAD) Ron Marcus, MD ISCTM Adaptive Design Workshop February 20, 2018 1 EPAD Goal The European Prevention of Alzheimer's Dementia (EPAD) project aims to develop
More informationdem Vascula perspective on frequency and risk factors. Last, but not least, we will consider treatment. PRACTICAL NEUROLOGY
86 PRACTICAL NEUROLOGY Vascula INTRODUCTION Vascular dementia is one of the most frequent causes of dementia in the elderly and therefore a major burden on health care systems in ageing societies. Cognitive
More informationInsulin-Leptin Interactions
Insulin-Leptin Interactions Ahmed S., Al-Azzam N., Cao B. Karshaleva B., Sriram S., Vu K. If you understand a system, you can predict it. Agenda - Energy homeostasis Overview of leptin and insulin Signaling
More informationX/08/$20.00/0 Endocrine Reviews 29(4): Copyright 2008 by The Endocrine Society doi: /er
0163-769X/08/$20.00/0 Endocrine Reviews 29(4):494 511 Printed in U.S.A. Copyright 2008 by The Endocrine Society doi: 10.1210/er.2007-0034 Cognitive Dysfunction and Diabetes Mellitus Christopher T. Kodl
More informationIsolated Post-challenge Hyperglycemia: Concept and Clinical Significance
CLINICAL PRACTICE Isolated Post-challenge Hyperglycemia: Concept and Clinical Significance John MF. Adam*, Daniel Josten** ABSTRACT The American Diabetes Association has strongly recommended that fasting
More informationInsulin Resistance. Biol 405 Molecular Medicine
Insulin Resistance Biol 405 Molecular Medicine Insulin resistance: a subnormal biological response to insulin. Defects of either insulin secretion or insulin action can cause diabetes mellitus. Insulin-dependent
More informationDementia and Healthy Ageing : is the pathology any different?
Dementia and Healthy Ageing : is the pathology any different? Professor David Mann, Professor of Neuropathology, University of Manchester, Hope Hospital, Salford DEMENTIA Loss of connectivity within association
More informationRisk Factors for Vascular Dementia: A Hospital-Based Study in Taiwan
22 Risk Factors for Vascular Dementia: A Hospital-Based Study in Taiwan Jun-Cheng Lin 1,2, Wen-Chuin Hsu 1, Hai-Pei Hsu 1,2, Hon-Chung Fung 1, and Sien-Tsong Chen 1 Abstract- Background: In Taiwan, next
More informationThe Cross-sectional Association Between Blood Pressure and Alzheimer s Disease in a Biracial Community Population of Older Persons
Journal of Gerontology: MEDICAL SCIENCES 2000, Vol. 55A, No. 3, M130 M136 Copyright 2000 by The Gerontological Society of America The Cross-sectional Association Between Blood Pressure and Alzheimer s
More informationThe incidence and prevalence of dementia are expected to increase several-fold in the
NEUROLOGICAL REVIEW Promising Strategies for the Prevention of Dementia Laura E. Middleton, PhD; Kristine Yaffe, MD The incidence and prevalence of dementia are expected to increase several-fold in the
More informationMidlife vascular risk factors and Alzheimer s disease in later life: longitudinal, population based study
Midlife vascular risk factors and Alzheimer s disease in later life: longitudinal, population based study Miia Kivipelto, Eeva-Liisa Helkala, Mikko P Laakso, Tuomo Hänninen, Merja Hallikainen, Kari Alhainen,
More informationVascular Dementia. Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center
Vascular Dementia Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center none Disclosures Objectives To review the definition of Vascular Cognitive Impairment (VCI);
More information